| Literature DB >> 34974686 |
Seong Jin Oh1, Kwang Seog Kim1, Jun Ho Choi1, Jae Ha Hwang1, Sam Yong Lee1.
Abstract
BACKGROUND: Transcutaneous lower eyelid approaches are associated with a risk of postoperative scarring depending on the distance between the incision line and the lower eyelid margin. The lower eyelid crease of Caucasians corresponds to a ridge-shaped fold in young Asians. However, this relationship has not been sufficiently evaluated in the latter. The authors, therefore, investigated the location of the scar and the lower eyelid crease or ridge to find the optimal location for the incision line.Entities:
Keywords: Ectropion; Eyelid; Facial bone; Scar
Year: 2021 PMID: 34974686 PMCID: PMC8721435 DOI: 10.7181/acfs.2021.00521
Source DB: PubMed Journal: Arch Craniofac Surg ISSN: 2287-1152
Fig. 1.Lower eyelid ridge in a young Asian. Thin pretarsal skin and thick preseptal skin form a natural ridge (black arrows) at a level similar to that of the lower eyelid crease in Caucasians. (A) Frontal view. (B) Oblique view.
Fig. 2.Study groups according to the location of the scar. Group A contains patients whose scar is located above the blue line. Group B comprises patients whose scar is located between the blue and red lines. Group C includes patients whose scar is located between the red line and 2 mm below the lower eyelid crease or ridge. Red line, lower eyelid crease or ridge; blue line, a virtual line 2 mm above the lower eyelid crease or ridge.
Fig. 3.Distance between the margins of the peripheral pupil and the lower eyelid (DMPE). The DMPE (yellow line) is checked by comparing this distance with that of the opposite eye. DMPE widening is defined as a difference between the two distances of more than 1 mm.
Summary of patient data
| Variable | Group A (n=23) | Group B (n=24) | Group C (n=13) | |
|---|---|---|---|---|
| Age (yr) | 43.2±17.2 | 41.8 ± 13.8 | 34.1 ± 17.3 | 0.127 |
| Fracture type | 0.311 | |||
| Tripod fracture | 16 (69.6) | 14 (58.3) | 9 (69.2) | |
| Inferior orbital wall fracture | 3 (13.0) | 8 (33.3) | 4 (30.8) | |
| Both | 4 (17.4) | 2 (8.3) | 0 | |
| Fracture site | 0.918 | |||
| Medial | 4 (17.4) | 5 (20.8) | 4 (30.8) | |
| Central | 14 (60.9) | 15 (62.5) | 7 (53.8) | |
| Lateral | 5 (21.7) | 4 (16.7) | 2 (15.4) | |
| POSAS | 22.7 ± 8.0 | 20.9 ± 2.4 | 32.5 ± 4.1 | < 0.001[ |
| Group A:Group B | 0.548 | |||
| Group B:Group C | < 0.001[ | |||
| Group A:Group C | < 0.001[ | |||
| DMS (mm) | 2.4 ± 0.5 | 4.1 ± 0.7 | 5.8 ± 0.6 | < 0.001[ |
| DMCR (mm) | 5.22 ± 0.60 | 5.00 ± 0.59 | 4.77 ± 0.60 | 0.113 |
| DMPE widening | 0.001[ | |||
| No | 16 (69.6) | 24 (100) | 13 (100) | |
| Yes | 7 (30.4) | 0 | 0 | |
| Ectropion | ||||
| No | 23 (100) | 24 (100) | 13 (100) | |
| Yes | 0 | 0 | 0 | |
| Lateral extension scar | 0.795 | |||
| No | 19 (82.6) | 21 (87.5) | 12 (92.3) | |
| Yes | 4 (17.4) | 3 (12.5) | 1 (7.7) | |
| Follow-up (mo) | 8.09 ± 2.92 | 9.25 ± 3.05 | 7.85 ± 2.88 | 0.298 |
Values are presented as mean±SD or number (%). Group A, ≥ 2 mm above the lower eyelid crease or ridge; group B, within lower eyelid crease or ridge to 2 mm above the lower eyelid crease or ridge; group C, within lower eyelid crease or ridge to 2 mm below the lower eyelid crease or ridge.
POSAS, Patient and Observer Scar Assessment Scale; DMS, distance between the lower eyelid margin and the scar; DMCR, distance between the lower eyelid margin and the lower eyelid crease or ridge; DMPE, distance between the margins of the peripheral pupil and the lower eyelid.
Analysis of variance or Fisher exact test for count data and Scheffé’s post-hoc test, statistically significant at p<0.05.
DMCR of both eyes in each group
| Group | DMCR (mm), mean ± SD | |
|---|---|---|
| Group A | 0.328 | |
| Fractured side | 5.22 ± 0.60 | |
| Normal side | 5.26 ± 0.62 | |
| Group B | 0.082 | |
| Fractured side | 5.00 ± 0.59 | |
| Normal side | 5.13 ± 0.68 | |
| Group C | 0.337 | |
| Fractured side | 4.77 ± 0.60 | |
| Normal side | 4.85 ± 0.69 |
Group A, ≥2 mm above the lower eyelid crease or ridge; group B, within lower eyelid crease or ridge to 2 mm above the lower eyelid crease or ridge; group C, within lower eyelid crease or ridge to 2 mm below the lower eyelid crease or ridge.
DMCR, distance between the lower eyelid margin and the lower eyelid crease or ridge.
Paired t-test, statistically significant at p<0.05.
POSAS score in each group
| Variable | Group A (n = 23) | Group B (n = 24) | Group C (n = 13) | |
|---|---|---|---|---|
| Observer component | ||||
| Vascularity | 1.3 ± 0.5 | 1.3 ± 0.5 | 1.5 ± 0.5 | 0.328 |
| Pigmentation | 1.1 ± 0.3 | 1.0 ± 0.2 | 1.3 ± 0.5 | 0.249 |
| Thickness | 1.7 ± 0.8 | 1.6 ± 0.5 | 1.7 ± 0.5 | 0.930 |
| Relief | 1.3 ± 0.4 | 1.1 ± 0.3 | 2.0 ± 0.4 | < 0.001[ |
| Pliability | 1.3 ± 0.5 | 1.2 ± 0.4 | 1.8 ± 0.4 | 0.006[ |
| Surface area | 1.5 ± 0.7 | 1.3 ± 0.5 | 1.6 ± 0.5 | 0.690 |
| Total score observer scar scale | 8.2 ± 2.3 | 7.5 ± 1.2 | 10.0 ± 1.2 | 0.025[ |
| Patient component | ||||
| Is the scar painful? | 1.3 ± 0.5 | 1.3 ± 0.6 | 1.6 ± 0.7 | 0.150 |
| Is the scar itching? | 1.8 ± 0.7 | 1.5 ± 0.6 | 1.8 ± 0.8 | 0.628 |
| Is the color of the scar different? | 2.2 ± 0.7 | 2.4 ± 0.7 | 3.9 ± 1.1 | < 0.001[ |
| Is the scar more stiff | 3.3 ± 2.0 | 2.8 ± 0.8 | 4.2 ± 2.0 | 0.270 |
| Is the thickness of the scar different? | 2.5 ± 1.1 | 2.8 ± 0.7 | 5.7 ± 1.3 | < 0.001[ |
| Is the scar irregular? | 3.3 ± 2.3 | 2.6 ± 0.8 | 5.3 ± 1.7 | 0.017[ |
| Total score patient scar scale | 14.5 ± 6.0 | 13.4 ± 2.0 | 22.5 ± 3.7 | < 0.001[ |
Values are presented as mean±SD. Group A, ≥ 2 mm above the lower eyelid crease or ridge; group B, within lower eyelid crease or ridge to 2 mm above the lower eyelid crease or ridge; group C, within lower eyelid crease or ridge to 2 mm below the lower eyelid crease or ridge.
POSAS, Patient and Observer Scar Assessment Scale.
Analysis of variance, statistically significant at p<0.05.
POSAS scores of postoperative scars and DMS
| Variable | Coefficient (95% CI) | |
|---|---|---|
| DMS | 2.40 (1.15 to 3.66) | < 0.001[ |
| Age | 0.07 (–0.04 to 0.18) | 0.186 |
| Follow-up | –0.12 (–0.68 to 0.44) | 0.674 |
| Lateral extension scar | 2.50 (–2.62 to 7.62) | 0.332 |
| Inferior orbital wall fracture | –1.32 (–5.57 to 2.92) | 0.534 |
| Tripod fracture and inferior orbital wall fracture | –2.18 (–8.04 to 3.68) | 0.459 |
POSAS, Patient and Observer Scar Assessment Scale; DMS, distance between the lower eyelid margin and the scar; CI, confidence interval.
Linear regression analysis, statistically significant at p<0.05.
DMS and DMPE widening
| OR (95% CI) | ||
|---|---|---|
| DMS | 0.14 (0.01–0.54) | 0.029[ |
| Age | 1.13 (1.03–1.33) | 0.048[ |
| Follow-up | 1.20 (0.79–1.93) | 0.392 |
| Lateral extension scar | 0.75 (0.04–12.01) | 0.841 |
DMS, distance between the lower eyelid margin and the scar; DMPE, distance between the margins of the peripheral pupil and the lower eyelid; OR, odds ratio; CI, confidence interval.
Logistic regression analysis, statistically significant at p<0.05.
Data summary of patients without DMPE widening
| Variable | Group A (n = 16) | Group B (n = 24) | Group C (n = 13) | |
|---|---|---|---|---|
| Age (yr) | 37.2 ± 16.8 | 41.8 ± 13.8 | 34.1 ± 17.3 | 0.660 |
| Fracture type | 0.541 | |||
| Tripod fracture | 10 (62.5) | 14 (58.3) | 9 (69.2) | |
| Inferior orbital wall fracture | 3 (18.8) | 8 (33.3) | 4 (30.8) | |
| Both | 3 (18.8) | 2 (8.3) | 0 | |
| Fracture site | 0.966 | |||
| Medial | 3 (18.8) | 5 (20.8) | 4 (30.8) | |
| Central | 10 (62.5) | 15 (62.5) | 7 (53.8) | |
| Lateral | 3 (18.8) | 4 (16.7) | 2 (15.4) | |
| POSAS | 17.7 ± 2.2 | 20.9 ± 2.4 | 32.5 ± 4.1 | < 0.001[ |
| Group A:Group B | 0.004[ | |||
| Group B:Group C | < 0.001[ | |||
| Group A:Group C | < 0.001[ | |||
| DMS (mm) | 2.5 ± 0.5 | 4.1 ± 0.7 | 5.8 ± 0.6 | < 0.001[ |
| DMCR (mm) | 5.12 ± 0.06 | 5.00 ± 0.59 | 4.77 ± 0.60 | 0.308 |
| DMPE widening | ||||
| No | 16 (100) | 24 (100) | 13 (100) | |
| Yes | 0 | 0 | 0 | |
| Ectropion | ||||
| No | 16 (100) | 24 (100) | 13 (100) | |
| Yes | 0 | 0 | 0 | |
| Lateral extension scar | 1.000 | |||
| No | 14 (87.5) | 21 (87.5) | 12 (92.3) | |
| Yes | 2 (12.5) | 3 (12.5) | 1 (7.7) | |
| Follow-up (mo) | 7.88 ± 2.87 | 9.25 ± 3.05 | 7.85 ± 2.88 | 0.263 |
Values are presented as mean±SD or number (%). Group A, ≥ 2 mm above the lower eyelid crease or ridge; group B, within lower eyelid crease or ridge to 2 mm above the lower eyelid crease or ridge; group C, within lower eyelid crease or ridge to 2 mm below the lower eyelid crease or ridge.
DMPE, distance between the margins of the peripheral pupil and the lower eyelid; POSAS, Patient and Observer Scar Assessment Scale; DMS, distance between the lower eyelid margin and the scar; DMCR, distance between the lower eyelid margin and the lower eyelid crease or ridge.
Analysis of variance or Fisher exact test for count data and Scheffé’s post-hoc test, statistically significant at p<0.05.
POSAS scores of postoperative scars and DMS (in patients without DMPE widening)
| Coefficient (95% CI) | ||
|---|---|---|
| DMS | 3.97 (3.20 to 4.74) | < 0.001[ |
| Age | –0.04 (–0.11 to 0.02) | 0.207 |
| Follow-up | –0.12 (–0.46 to 0.22) | 0.407 |
| Lateral extension scar | 0.39 (–2.87 to 3.65) | 0.810 |
| Inferior orbital wall fracture | –1.05 (–3.47 to 1.37) | 0.387 |
| Tripod fracture and inferior orbital wall fracture | –1.76 (–5.40 to 1.87) | 0.334 |
POSAS, Patient and Observer Scar Assessment Scale; DMS, distance between the lower eyelid margin and the scar; DMPE, distance between the margins of the peripheral pupil and the lower eyelid; CI, confidence interval.
Linear regression analysis, statistically significant at p<0.05.
Fig. 4.Lower eyelid crease and ridge. (A) In Caucasians, the lower eyelid crease is formed by the fascial extensions of the capsulopalpebral fascia, which also pass through the orbicularis oculi muscle and insert into the skin. (B) In young Asians, the crease is absent or ambiguous, or is replaced with a transverse ridge due to higher or indistinct septum fusion, anterior and superior orbital fat projection, and overriding of the preseptal orbicularis muscle.